Abbott Diabetes Care is a supporter of Time In Range, the American Diabetes Association’s nationwide effort to encourage measuring and monitoring of blood glucose levels ‘beyond A1C’ to improve outcomes and better manage diabetes. In addition, Abbott is a Founding Sponsor of Health Equity Now, a national platform to ensure that all people living with diabetes, and the millions of underserved Americans who are at greatest risk for diabetes, have access to health resources that are too often unavailable to them. Abbott also supports the American Diabetes Association’s Amputation Prevention Campaign to help disrupt the curve of amputations among low-income and minority individuals with diabetes.

Bayer Healthcare is a national sponsor of the American Diabetes Association’s Know Diabetes By Heart campaign alongside the American Heart Association. This initiative’s purpose is to reduce cardiovascular death (CVD), heart attack, heart failure and stroke in people living with type 2 diabetes (T2D).

Eli Lilly and Company has provided funding for scholarships for families needing economic assistance to send their children to diabetes camp for more than 20 years. They were a founding sponsor of Pathway to Stop Diabetes, a research program designed to find the next generation of diabetes researchers and serve as a national sponsor of Project Power for adults.

Medtronic Diabetes is a sponsor of Health Equity Now, a national platform to ensure that all people living with diabetes, and the millions of underserved Americans who are at greatest risk for diabetes, have access to health resources that are too often unavailable to them. Medtronic also supports the American Diabetes Association’s Amputation Prevention Campaign to help disrupt the curve of amputations among low-income and minority individuals with diabetes.

Novo Nordisk is a sponsor of the American Diabetes Association’s (ADA) Imagine Camps. ADA Imagine Camp is designed to facilitate a free, at-home virtual experience, providing opportunities for children with diabetes to connect as never before! Novo Nordisk also continues to support Scientific Sessions, the world's largest meeting on diabetes. 

Novo has also helped to support the launch and execution of the diabetes cardiovascular initiative Know Diabetes by Heart™, which is a collaboration between the American Diabetes Association and the American Heart Association.

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company that discovers, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions, is a Visionary Partner of the American Diabetes Association^® Eye Health Initiative, Focus on Diabetes™ and a Banting Circle Elite Partner. Together with the ADA, Regeneron joined this initiative with the goal of reducing the risk of diabetes-related eye disease through increased awareness, screening, prevention, and early intervention.

Sanofi supports phase 3 of ADA’s Therapeutic Inertia program. The main goal of phase 3 is to promote the measurable adoption of evidence-based practices, strategies, programs and tools that address key barriers associated with therapeutic inertia in diabetes care, leading to improved, timely treatment modification and improved overall glycemic control in adult patients with type 2 diabetes. Sanofi also supported the American Diabetes Association’s 100 Years of Insulin, a year-long campaign that focused on awareness, education and promoting activities that build community.